5187
CREATE MEDIC CO.,LTD.
クリエートメディック
- Industry
- Precision Instruments
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Dec 2021
11,698,682
Dec 2022
12,257,294
Dec 2023
12,585,449
Dec 2024
13,030,322
Dec 2025
13,617,561
Operating profit(thousand JPY)
Dec 2021
866,784
Dec 2022
737,711
Dec 2023
803,242
Dec 2024
692,456
Dec 2025
1,005,082
Operating profit margin(%)
Dec 2021
7.41
Dec 2022
6.02
Dec 2023
6.38
Dec 2024
5.31
Dec 2025
7.38
Profit before tax(thousand JPY)
Dec 2021
965,626
Dec 2022
836,742
Dec 2023
904,024
Dec 2024
1,086,827
Dec 2025
1,060,748
Profit(thousand JPY)
Dec 2021
660,409
Dec 2022
460,645
Dec 2023
154,022
Dec 2024
840,901
Dec 2025
713,734
Total assets(thousand JPY)
Dec 2021
18,075,741
Dec 2022
18,865,564
Dec 2023
19,258,777
Dec 2024
20,047,668
Dec 2025
20,143,280
Cash and cash equivalents(thousand JPY)
Dec 2021
3,413,673
Dec 2022
3,702,277
Dec 2023
3,770,745
Dec 2024
5,662,061
Dec 2025
5,060,622
Cash flows from operating activities(thousand JPY)
Dec 2021
1,248,681
Dec 2022
461,344
Dec 2023
698,839
Dec 2024
2,249,762
Dec 2025
530,120
Cash flows from investing activities(thousand JPY)
Dec 2021
-585,010
Dec 2022
38,014
Dec 2023
-363,614
Dec 2024
270,619
Dec 2025
-573,078
Cash flows from financing activities(thousand JPY)
Dec 2021
-442,519
Dec 2022
-355,587
Dec 2023
-362,190
Dec 2024
-877,650
Dec 2025
-600,389
Return on equity(%)
Dec 2021
4.8
Dec 2022
3.2
Dec 2023
1
Dec 2024
5.5
Dec 2025
4.4
Equity ratio(%)
Dec 2021
78.7
Dec 2022
78
Dec 2023
77.6
Dec 2024
78.6
Dec 2025
81.1
Earnings per share(JPY per share)
Dec 2021
72.61
Dec 2022
50.63
Dec 2023
16.92
Dec 2024
95.41
Dec 2025
84.25
Net assets per share(JPY per share)
Dec 2021
1,563.55
Dec 2022
1,618.1
Dec 2023
1,641.59
Dec 2024
1,833.67
Dec 2025
1,947.68
Dividend per share(JPY per share)
Dec 2021
37
Dec 2022
37
Dec 2023
37
Dec 2024
39
Dec 2025
45
Payout ratio(%)
Dec 2021
50.96
Dec 2022
73.08
Dec 2023
218.68
Dec 2024
40.88
Dec 2025
53.41
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.